Page 10 - guidelines_2018_english

Declarations of Interests

The members of the Editorial Board of the ENSP Guidelines for SRL, CROM Research Org. SRL, INC Research and Glaxo
Treating Tobacco Dependence declare the following declarations SmithKline during 2011-2012 and has received fees for occasional
of interest: lectures from the European Commission, AstraZeneca, Servier
Pharma SRL, Glaxo SmithKline and Pierre-Fabre during 2011-
Panagiotis K. Behrakis declares to have no conflict of interest 2012;
with any pharmaceutical company;
Sophia Papadakis declares that her institute has been awarded
Luke Clancy declares that his institute was awarded a research educational grants by Pfizer; but has refused any
grant by Pfizer in 2010; he received consultancy fees personal fees from pharmaceutical companies or other agencies;
from Pfizer and Pierre Fabre 2010, 2011, 2012; he received lecture
fees from Pfizer and Novartis in 2010, 2011, 2012; Constantine Vardavas declares that his institute has been
awarded educational grants by Pfizer; but has refused any
Bertrand Dautzenberg has collaborated for the past three years, personal fees from pharmaceutical companies or other agencies.
but has refused any personal fees from Pfizer,
GlaxoSmithKline;

Hans Gilljam declares that he has no relation to the pharmaceutical
industry;
Antigona Trofor has received regular paid consultancy funds for
clinical research work from Novartis Pharma Services Romania

8